CK-103

N/A

Report date: 2024/05/09 16:47:20
NME

Base Information

Drug NameCK-103
Drug Alias NameCK-103TG-1601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitorsBromodomain-containing protein 4 inhibitors
TargetsBromodomain and extra terminal domain proteinBromodomain-containing protein 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJubilant Pharma
China Registration ClassN/A

Develop Information

Active CompaniesTg Therapeutics IncCheckpoint Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A